2014 Annual Paris Melanoma Conference webcast

2014 Annual Paris Melanoma Conference webcast

View Webcast

Activity Features

Downloadable Slides

Activity Overview

This Webcast contains video and downloadable slides from the 2014 Annual Paris Melanoma Conference, a prIME Oncology educational activity that was held on 4-5 July 2014 in Paris, France.


Inflammation-induced phenotypic plasticity and immune escape
Presented by: Thomas Tüting, MD

Investigating drivers for migration in a Caenorhabditis elegansmodel
Presented by: Reinhard Dümmer, MD

Primary tumors versus metastasis: New experimental models for cancer cell homing
Presented by: Iris Helfrich, PhD

Linking cancer exomes to cancer immunotherapy
Presented by: John B. A. G. Haanen, MD, PhD

Combinations of immunotherapies: Ongoing and upcoming trials
Presented by: Jeffrey S. Weber, MD, PhD

Brain metastases: Targeted therapy or immunotherapy?
Presented by: Georgina Long, MBBS, PhD

Combinations of targeted therapies: Which intra/interpathway strategies?
Presented by: Keith Flaherty, MD

Talimogene laherparepvec (TVEC): Current results and future directions
Presented by: Yvonne Saenger, MD

The Italian electrochemotherapy experience
Presented by: Luca Campana

Applications of the renal cell cancer experience to melanoma
Presented by: James Larkin, FRCP, PhD


  • Reinhard Dummer, MDUniversity of Zurich Hospital
    Zurich, Switzerland
  • Luca Campana, MD, PhDVeneto Institute of Oncology (IOV-IRCCS)
    Padova, Italy
  • Keith Flaherty, MDMassachusetts General Hospital Cancer Center
    Boston, Massachusetts, United States
  • John B. A. G. Haanen, MD, PhDThe Netherlands Cancer Institute
    Amsterdam, the Netherlands
  • Iris Helfrich, PhDUniversity Clinic Essen
    Essen, Germany
  • James Larkin, FRCP, PhDThe Royal Marsden
    London, United Kingdom
  • Georgina Long, MBBS, PhDMelanoma Institute of Australia
    University of Sydney
    Sydney, Australia
  • Yvonne Saenger, MDThe Mount Sinai Hospital
    New York, New York, United States
  • Thomas Tuting, MDUniversity Hospital Bonn
    Bonn, Germany
  • Jeffrey S. Weber, MD, PhDLaura and Isaac Perlmutter Cancer Center
    NYU Langone Medical Center
    New York, New York, United States

Target Audience

This educational activity is specifically designed for medical and surgical oncologists, dermatologists, research scientists, and other healthcare professionals interested in the treatment of patients with melanoma.

Learning Objectives

Upon completion of this educational activity, attendees should be able to:

  • Discuss recent progress in the understanding of melanoma biology, including advances in epidemiology, diagnosis, classification, and biomarkers
  • Describe current standards of care and recent advances in the treatment of patients with melanoma, including emerging strategies for adjuvant and neoadjuvant therapy
  • Examine the evolving role of targeted therapies and immunotherapies in the treatment of melanoma
  • Assess new data from melanoma clinical trials and novel clinical trial designs to address unanswered questions in the field
View Webcast


This activity is provided by prIME Oncology.


Support for this educational activity is provided by Bristol-Myers Squibb; MSD; Amgen Oncology; and GSK.

Activity Date

September 9, 2014

September 9, 2015